📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
476 analysed today
FollowTelegram
476
Today
150,427
All-time analysed
43,086
Positive
6,691
Negative
91,899
Neutral
8,683
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
22 announcements match the current filters (relevance ≥ 5).
Zydus Wellness Q3 Standalone Revenue Jumps 53% to ₹1,526 Million; Net Profit at ₹121 Million
Zydus Wellness reported a robust 53% year-on-year growth in standalone revenue for Q3 FY26, reaching ₹1,526 million. However, standalone net profit remained nearly flat at ₹121 million compared to ₹118 million in the previous year, primarily due to higher material costs and exceptional items. The company recognized a ₹15 million one-time charge related to the New Labour Codes and completed the consolidation of Naturell (India) Private Limited. Investors should note a significant net loss of ₹1,062 million reported by a key subsidiary in the consolidated results, which may weigh on overall group performance.
Key Highlights
Standalone Revenue from operations increased 53% YoY to ₹1,526 million from ₹997 million.
Standalone Net Profit stood at ₹121 million, showing a marginal 2.5% growth YoY.
Exceptional items include ₹15 million for New Labour Code compliance and ₹97 million related to Naturell India liquidation.
A major subsidiary reported a significant net loss of ₹1,062 million for the quarter ended December 31, 2025.
Equity shares were successfully sub-divided from a face value of ₹10 to ₹2 effective September 19, 2025.
👀 What to Watch
While standalone revenue growth is impressive, investors should exercise caution due to the substantial losses reported in the consolidated subsidiary. Monitor the management's commentary on the turnaround of subsidiary operations and the margin pressure from rising material costs.
Zydus Wellness Gets Interim Relief from Gujarat HC on ₹56.33 Crore GST Demand
Zydus Wellness's subsidiary, ZWPL, has secured ad-interim relief from the Gujarat High Court regarding a GST demand of ₹56.33 crores plus interest and penalties. The court has restrained further proceedings related to the Order-in-Original dated September 30, 2025. Crucially, the company stated that the tax liability pertains to the period before January 30, 2019, which is prior to the acquisition. This liability is fully indemnified by Heinz Italia S.P.A., meaning there is no direct financial impact on Zydus Wellness.
Key Highlights
Gujarat High Court granted ad-interim relief restraining proceedings for a ₹56.33 crore GST demand.
The demand was issued by the DGGI, Surat Zonal Unit, under Section 74(5) of the CGST Act.
The tax dispute relates to the pre-acquisition period prior to January 30, 2019.
Liability is fully indemnified by Heinz Italia S.P.A., protecting the company's balance sheet.
The writ petition was filed under Article 226 of the Constitution of India challenging the OIO.
👀 What to Watch
Investors should take comfort in the fact that the liability is indemnified by the previous owner, Heinz, and the court has stayed the proceedings. No immediate negative impact on the company's financials is expected.
